Disease-Modifying Treatments for Myasthenia Gravis
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Donald Sanders, MD
Duke University
Principal Investigator - Jeffery Guptill, MD
Duke University
Principal Investigator - Pushpa Narayanaswami, MD
Beth Israel Deaconess Medical Center
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
19 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of Alberta Hospital, Faculty of Medicine
Edmonton, Alberta, Canada
- London Health Sciences Centre
London, Ontario, Canada
- Stanford University
Palo Alto, California, United States
- Unversity of Miami
Miami, Florida, United States
- Rush University Medical Center
Chicago, Illinois, United States
- Ochsner Clinic Foundation
New Orleans, Louisiana, United States
- Beth Israel Deaconess Medical Center
Boston, Massachusetts, United States
- Brigham and Women'S Hospital
Boston, Massachusetts, United States
- Massachusetts General Hospital
Boston, Massachusetts, United States
- St. Elizabeth'S Medical Center
Brighton, Massachusetts, United States
- University at Buffalo, Suny
Buffalo, New York, United States
- University of Rochester Medical Center
Rochester, New York, United States
- University of North Carolina at Chapel Hill
Chapel Hill, North Carolina, United States
- Duke University
Durham, North Carolina, United States
- Cleveland Clinic
Cleveland, Ohio, United States
- University of Pennsylvania
Philadelphia, Pennsylvania, United States
- University of Pittsburgh
Pittsburgh, Pennsylvania, United States
- Medical University of South Carolina
Charleston, South Carolina, United States
- University of Vermont - Larner College of Medicine
Burlington, Vermont, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 7 May 2018
- Primary completion
- 31 Jan 2021
- Completion
- 31 Jan 2021
- Last update posted
- 18 Jun 2026
- Registered enrollment
- 82
- Registry id
- NCT03490539
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.